MapLight Therapeutics, Inc. (MPLT)

13.78 +0.64 (+4.91%) USD  |  NASDAQ  |  Sep 04, 16:00
13.78 0.00 (0.00%) After-Hours: 18:22
More

MapLight Therapeutics Cash and Short Term Investments (Annual) : 305.10M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for MPLT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2022. Start Trial.
Date Value
December 31, 2025 305.10M
December 31, 2024 108.80M
Date Value
December 31, 2023 79.77M
December 31, 2022 27.66M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Evommune, Inc. 149.20M
Sarepta Therapeutics, Inc. 939.65M
Cullinan Therapeutics, Inc. 377.90M
Mineralys Therapeutics, Inc. 656.64M
Apogee Therapeutics, Inc. 730.19M